Junmin Whiting
Impact in
-
- Vaccine Coverage and Hesitancy
-
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
Papers in
- Co-authors
- Anna R. Giuliano (13 shared papers)Shannon M. Christy (8 shared papers)Naomi C. Brownstein (9 shared papers)Cathy D. Meade (7 shared papers)Clement K. Gwede (7 shared papers)Susan T. Vadaparampil (8 shared papers)Katharine J. Head (7 shared papers)Monica L. Kasting (7 shared papers)
- Journals
- Blood (5 papers)Journal of Clinical Oncology (4 papers)Cancers (3 papers)The Oncologist (2 papers)Oncology (2 papers)
- Partner nations
- United StatesPuerto RicoCanada
In The Last Decade
Junmin Whiting
44 papers receiving 242 citations
Peers
Comparison fields: 5 of 51
- Health 29
- Oncology 63
- Infectious Diseases 35
- Cancer Research 27
- Epidemiology 40
Countries citing papers authored by Junmin Whiting
This map shows the geographic impact of Junmin Whiting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junmin Whiting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junmin Whiting more than expected).
Fields of papers citing papers by Junmin Whiting
This network shows the impact of papers produced by Junmin Whiting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junmin Whiting. The network helps show where Junmin Whiting may publish in the future.
Co-authors
The 25 scholars most cited alongside Junmin Whiting, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 21 | |
| 2 | 2022 | 19 | |
| 3 | 2022 | 19 | |
| 4 | 2022 | 17 | |
| 5 | 2022 | 14 | |
| 6 | 2023 | 13 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 8 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 8 | |
| 11 | 2023 | 8 | |
| 12 | 2022 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2021 | 7 | |
| 15 | 2022 | 6 | |
| 16 | 2023 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2024 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2021 | 4 |
About Junmin Whiting
Junmin Whiting is a scholar working on Oncology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Epidemiology, having authored 56 papers that have together received 246 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (8 papers), Cervical Cancer and HPV Research (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Cancer Treatment and Pharmacology (4 papers), Advanced Breast Cancer Therapies (4 papers), HER2/EGFR in Cancer Research (4 papers) and Genital Health and Disease (3 papers). The work is most often cited by research in Health (29 citations), Oncology (63 citations), Infectious Diseases (35 citations), Cancer Research (27 citations) and Epidemiology (40 citations). Junmin Whiting has collaborated with scholars based in United States, Puerto Rico and Canada. Frequent co-authors include Anna R. Giuliano, Shannon M. Christy, Naomi C. Brownstein, Cathy D. Meade, Clement K. Gwede, Susan T. Vadaparampil, Katharine J. Head, Monica L. Kasting, Jessica Y. Islam and Marie Catherine Lee. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancers, The Oncologist and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.